Abstract
Substituted 4-amino cyclohexylglycine analogues were evaluated for DP-IV inhibitory properties. Bis-sulfonamide 15e was an extremely potent 2.6 nM inhibitor of the enzyme with excellent selectivity over all counterscreens. 2,4-difluorobenzenesulfonamide 15b and 1-naphthyl amide 16b, however, combined an acceptable in vitro profile with good pharmacokinetic properties in the rat, and 15b was orally efficacious at 3 mpk in an OGTT in lean mice.
MeSH terms
-
Animals
-
Cation Transport Proteins / metabolism
-
Dipeptidyl Peptidase 4 / metabolism*
-
Ether-A-Go-Go Potassium Channels
-
Glycine / analogs & derivatives*
-
Glycine / metabolism*
-
Hypoglycemic Agents / chemistry
-
Hypoglycemic Agents / metabolism
-
Hypoglycemic Agents / pharmacokinetics
-
Mice
-
Potassium Channels / metabolism
-
Potassium Channels, Voltage-Gated*
-
Protease Inhibitors / chemistry
-
Protease Inhibitors / metabolism*
-
Protease Inhibitors / pharmacokinetics
-
Protein Binding / drug effects
-
Protein Binding / physiology
-
Rats
Substances
-
Cation Transport Proteins
-
Ether-A-Go-Go Potassium Channels
-
Hypoglycemic Agents
-
KCNH6 protein, human
-
Potassium Channels
-
Potassium Channels, Voltage-Gated
-
Protease Inhibitors
-
Dipeptidyl Peptidase 4
-
Glycine